Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Capital/Financing Update 2025

Nov 2, 2025

66262_rns_2025-11-03_d5a4fae4-c29b-4f38-a2b7-057988ccbc00.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [101 x 28] intentionally omitted <==

QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED (“RUARB”) RIGHTS

Issuer: Rua Bioscience Limited (“RUA”) Ticker Code: RUARB ISIN: NZRUAE0006S6 Details of Issue: A pro-rata renounceable rights issue of 1 new share for every 3 existing shares held on the Record Date. Ratio (New: Existing): 1 : 3 Exercise Price: NZ$0.025 per new share Reference Price: Calculated as head share price prior to quotation minus the Exercise Price Issue Price Payable: In full on application Registrar: Computershare Investor Services Limited (“RMLT”) Settlement Status: NZCDC Settlement System Key Dates Ex Rights Date: Friday, 7 November 2025 Rights Commence Trading: Friday, 7 November 2025 Record Date: 5pm, Monday, 10 November 2025 Letters of Entitlement sent to Tuesday, 11 November 2025 Shareholders: Offer Opens: Tuesday, 11 November 2025 Rights Quotation Ceases: Monday, 24 November 2025 Offer Closes: Friday, 28 November 2025 Allotment and commencement of Thursday, 4 December 2025 trading of New Shares (retail offer):

==> picture [137 x 65] intentionally omitted <==

Mark Peterson Chief Executive Officer NZX Limited

3 November 2025